JAZZ
Jazz Pharmaceuticals plc
NASDAQ · Healthcare · Biotechnology · IE
$246.81
−0.30%Forward multiples
Based on analyst estimates
- P/E forward
- 9.78x
- P/E 2026E
- 9.87x
- P/E 2027E
- 9.54x
- P/E 2028E
- 8.25x
- P/S forward
- 3.30x
Trailing multiples
Trailing twelve months
- P/E TTM
- 16.24x
- PEG TTM
- 0.25x
- Price / book
- 3.34x
- Price / sales
- 3.48x
- Price / cash flow
- 9.65x
Enterprise value
- Enterprise value
- $18.2B
- EV / sales
- 3.96x
- EV / EBITDA
- 12.35x
- EV / EBIT
- 12.76x
- Market cap
- $16.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026